{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:34:36Z","timestamp":1740720876354,"version":"3.38.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ccep.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T09:38:10Z","timestamp":1289381890000},"page":"379-391","source":"Crossref","is-referenced-by-count":0,"title":["Antiarrhythmic Drug Therapy of Supraventricular Tachycardia"],"prefix":"10.1016","volume":"2","author":[{"given":"Steven A.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccep.2010.07.003_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib2","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","volume":"108","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199501193320307","article-title":"Supraventricular tachycardia","volume":"332","author":"Ganz","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.CIR.0000059743.36226.E8","article-title":"Contemporary management of paroxysmal supraventricular tachycardia","volume":"107","author":"Ferguson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1021171922099","article-title":"Electrophysiological evaluation and ablation of atypical right atrial flutter","volume":"6","author":"Shah","year":"2002","journal-title":"Card Electrophysiol Rev"},{"key":"10.1016\/j.ccep.2010.07.003_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.CIR.88.1.282","article-title":"Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations","volume":"88","author":"Akhtar","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.41.4.415","article-title":"Action potentials, afterpotentials, and arrhythmias","volume":"41","author":"Cranefield","year":"1977","journal-title":"Circ Res"},{"key":"10.1016\/j.ccep.2010.07.003_bib8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0002-8703(83)90003-0","article-title":"Pathophysiologic mechanisms of cardiac arrhythmias","volume":"106","author":"Wit","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib9","doi-asserted-by":"crossref","first-page":"9A","DOI":"10.1016\/0002-9149(88)90736-9","article-title":"Mechanisms of clinical tachycardias","volume":"61","author":"Akhtar","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1378\/chest.88.6.931","article-title":"Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man","volume":"88","author":"Marchlinski","year":"1985","journal-title":"Chest"},{"issue":"Suppl B","key":"10.1016\/j.ccep.2010.07.003_bib11","doi-asserted-by":"crossref","first-page":"67B","DOI":"10.1016\/S0828-282X(07)71013-9","article-title":"Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital","volume":"23","author":"O\u2019Hara","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1540-8159.2000.tb00891.x","article-title":"The 1998 NASPE prospective catheter ablation registry","volume":"23","author":"Scheinman","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib13","first-page":"261","article-title":"Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia","volume":"9","author":"Parker","year":"1990","journal-title":"Clin Pharm"},{"key":"10.1016\/j.ccep.2010.07.003_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0735-1097(93)90185-4","article-title":"Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia","volume":"22","author":"McIntosh-Yellin","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group","volume":"113","author":"DiMarco","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9343(92)90784-9","article-title":"Adenosine and the treatment of supraventricular tachycardia","volume":"92","author":"Rankin","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3565(25)20409-8","article-title":"Caffeine and theophylline as adenosine receptor antagonists in humans","volume":"258","author":"Biaggioni","year":"1991","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ccep.2010.07.003_bib18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.83.5.1499","article-title":"Cardiac electrophysiology of adenosine. Basic and clinical concepts","volume":"83","author":"Lerman","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/clc.4960211009","article-title":"Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias","volume":"21","author":"Donahue","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib20","first-page":"141","article-title":"Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia","volume":"46","author":"Sethi","year":"1994","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000063331","article-title":"Differential effects of adenosine on antegrade fast pathway, antegrade slow pathway, and retrograde fast pathway in atrioventricular nodal reentry","volume":"97","author":"Lai","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.ccep.2010.07.003_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1540-8167.1998.tb00121.x","article-title":"Differential effect of adenosine on anterograde and retrograde fast pathway conduction in patients with atrioventricular nodal reentrant tachycardia","volume":"9","author":"Souza","year":"1998","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1253\/jcj.61.323","article-title":"Effects of adenosine triphosphate on ventriculoatrial conduction\u2014usefulness and problems in assessment of catheter ablation of accessory pathways","volume":"61","author":"Miyata","year":"1997","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ccep.2010.07.003_bib24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/clc.4960230806","article-title":"High variability of retrograde fast pathway sensitivity to adenosine","volume":"23","author":"Mewis","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib25","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.0000040587.73251.48","article-title":"Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping","volume":"106","author":"Iwai","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1540-8159.1995.tb02520.x","article-title":"Adenosine-sensitive atrial tachycardia","volume":"18","author":"Kall","year":"1995","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib27","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.89.6.2645","article-title":"Mechanism-specific effects of adenosine on atrial tachycardia","volume":"89","author":"Engelstein","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00045391-200203000-00008","article-title":"Proarrhythmic effects of adenosine: one decade of clinical data","volume":"9","author":"Pelleg","year":"2002","journal-title":"Am J Ther"},{"key":"10.1016\/j.ccep.2010.07.003_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.pec.0000199558.88733.49","article-title":"Induction of atrial fibrillation after the routine use of adenosine","volume":"22","author":"Kaltman","year":"2006","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.ccep.2010.07.003_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-127-6-199709150-00001","article-title":"Adenosine-induced atrial arrhythmia: a prospective analysis","volume":"127","author":"Strickberger","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1096\/fasebj.9.5.7896004","article-title":"Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes","volume":"9","author":"Belardinelli","year":"1995","journal-title":"FASEB J"},{"key":"10.1016\/j.ccep.2010.07.003_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1527-3466.2003.tb00122.x","article-title":"CVT-510: a selective A1 adenosine receptor agonist","volume":"21","author":"Cheung","year":"2003","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.ccep.2010.07.003_bib33","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/CIRCULATIONAHA.104.510982","article-title":"Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson","volume":"111","author":"Ellenbogen","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib34","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0735-1097(03)00987-2","article-title":"Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist","volume":"42","author":"Prystowsky","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1460-9592.2001.00450.x","article-title":"Adenosine induced ventricular arrhythmias in the emergency room","volume":"24","author":"Tan","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1542-474X.2008.00245.x","article-title":"Adenosine-induced ventricular arrhythmias in patients with supraventricular tachycardias","volume":"13","author":"Ertan","year":"2008","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib37","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ijcard.2007.07.068","article-title":"Sustained monomorphic ventricular tachycardia after adenosine infusion","volume":"131","author":"Huemer","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib38","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/archinte.1993.00410230125015","article-title":"Ventricular fibrillation following adenosine administration. A case report","volume":"153","author":"Ben-Sorek","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1460-9592.2002.00477.x","article-title":"Adenosine induced ventricular fibrillation in Wolff-Parkinson-White syndrome","volume":"25","author":"Gupta","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib40","first-page":"208","article-title":"Adenosine-induced ventricular fibrillation","volume":"53","author":"Shah","year":"2001","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1009810025584","article-title":"Case report: adenosine induced ventricular fibrillation in a patient with stable ventricular tachycardia","volume":"5","author":"Parham","year":"2001","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib42","doi-asserted-by":"crossref","first-page":"901.e1","DOI":"10.1016\/j.ajem.2008.11.008","article-title":"Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia","volume":"27","author":"Walsh","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1540-8167.1999.tb00705.x","article-title":"Differential effects of adenosine on focal and macroreentrant atrial tachycardia","volume":"10","author":"Markowitz","year":"1999","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.80.4.465","article-title":"Treatment of supraventricular arrhythmias with intravenous and oral verapamil","volume":"80","author":"Gonzalez","year":"1981","journal-title":"Chest"},{"key":"10.1016\/j.ccep.2010.07.003_bib45","doi-asserted-by":"crossref","first-page":"59D","DOI":"10.1016\/0002-9149(87)90710-7","article-title":"Efficacy and safety of intravenous nadolol for supraventricular tachycardia","volume":"60","author":"Olukotun","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-8703(86)90513-2","article-title":"Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group","volume":"112","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-8703(85)90185-1","article-title":"Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial","volume":"110","author":"Abrams","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib48","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0196-0644(95)70179-6","article-title":"A\u00a0comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting","volume":"25","author":"Madsen","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9149(82)90285-5","article-title":"Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia","volume":"49","author":"Klein","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.CIR.77.4.795","article-title":"Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia","volume":"77","author":"Belhassen","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1553-2712.1996.tb03467.x","article-title":"Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil","volume":"3","author":"Brady","year":"1996","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archinte.1986.00360180067011","article-title":"Treatment of atrial arrhythmias. Effectiveness of verapamil when preceded by calcium infusion","volume":"146","author":"Haft","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.resuscitation.2009.01.017","article-title":"Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia","volume":"80","author":"Lim","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.ccep.2010.07.003_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.65.2.348","article-title":"Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil","volume":"65","author":"Gulamhusein","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0196-0644(85)81080-5","article-title":"Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation","volume":"14","author":"Jacob","year":"1985","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib56","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0735-1097(89)90589-5","article-title":"Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study","volume":"13","author":"Huycke","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem study group","volume":"70","author":"Dougherty","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib58","first-page":"125","article-title":"Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias","volume":"50","author":"Boudonas","year":"1995","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/clc.4960090403","article-title":"Intravenous diltiazem for the treatment of supraventricular tachycardia","volume":"9","author":"Sternbach","year":"1986","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib60","first-page":"969","article-title":"Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia","volume":"47","author":"Gupta","year":"1999","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.ccep.2010.07.003_bib61","first-page":"288","article-title":"Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent","volume":"5","author":"Angaran","year":"1986","journal-title":"Clin Pharm"},{"key":"10.1016\/j.ccep.2010.07.003_bib62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.CIR.71.1.104","article-title":"Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol","volume":"71","author":"Yeh","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia","volume":"37","author":"Alboni","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib64","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0002-8703(87)90500-X","article-title":"Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility","volume":"114","author":"Hamer","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-8703(86)90471-0","article-title":"Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil","volume":"112","author":"Rose","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/01.CIR.50.1.114","article-title":"Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome","volume":"50","author":"Wellens","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/clpt.1987.82","article-title":"Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide","volume":"41","author":"Windle","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccep.2010.07.003_bib68","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1253\/jcj.47.98","article-title":"Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias","volume":"47","author":"Hiejima","year":"1983","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ccep.2010.07.003_bib69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0735-1097(88)90106-4","article-title":"Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up","volume":"11","author":"Mehta","year":"1988","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib70","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1540-8167.2001.00852.x","volume":"12","author":"Saoudi","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib71","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(84)90498-3","article-title":"Electrophysiologic properties of flecainide acetate","volume":"53","author":"NA 3rd","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9149(83)80131-3","article-title":"Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias","volume":"51","author":"Hellestrand","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0002-9149(88)90217-2","article-title":"Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia","volume":"62","author":"Musto","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib74","first-page":"237","article-title":"Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia","volume":"47","author":"Gambhir","year":"1995","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0002-8703(92)90927-N","article-title":"Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults","volume":"124","author":"Musto","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib76","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0002-9149(82)90423-4","article-title":"Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction","volume":"50","author":"Vik-Mo","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/oxfordjournals.eurheartj.a061621","article-title":"The multiple modes of action of propafenone","volume":"5","author":"Dukes","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib78","first-page":"5","article-title":"Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation","volume":"43","author":"Sethi","year":"1991","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib79","doi-asserted-by":"crossref","first-page":"9D","DOI":"10.1016\/S0002-9149(84)80278-7","article-title":"Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations","volume":"54","author":"Siddoway","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/oxfordjournals.eurheartj.a062159","article-title":"Lack of clinically significant beta-blocking effect of propafenone","volume":"8","author":"Cheriex","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib81","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199006213222502","article-title":"The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone","volume":"322","author":"Lee","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib82","doi-asserted-by":"crossref","first-page":"66N","DOI":"10.1016\/S0002-9149(98)00587-6","article-title":"Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis","volume":"82","author":"Reimold","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2006.00353.x","article-title":"Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia","volume":"29","author":"Eidher","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib84","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","article-title":"Electrophysiological effects of ibutilide in patients with\u00a0accessory pathways","volume":"104","author":"Glatter","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2010.04.026","article-title":"Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)","author":"Andrade","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2010.07.003_bib86","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/oxfordjournals.eurheartj.a059430","article-title":"Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol","volume":"10","author":"Waleffe","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-8703(84)90367-3","article-title":"Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone","volume":"107","author":"Gomes","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCEP.109.901629","article-title":"Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients","volume":"3","author":"Chang","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1253\/jcj.63.189","article-title":"Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome","volume":"63","author":"Kuga","year":"1999","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ccep.2010.07.003_bib90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S148180350001441X","article-title":"Myth: intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department","volume":"7","author":"Tijunelis","year":"2005","journal-title":"CJEM"},{"key":"10.1016\/j.ccep.2010.07.003_bib91","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-010-0385-6","article-title":"Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation","author":"Simonian","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib92","first-page":"IV31","article-title":"Use of calcium channel entry blockers in the treatment of cardiac arrhythmias","volume":"80","author":"Akhtar","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00005344-198201000-00003","article-title":"Metoprolol in the treatment and prophylaxis of paroxysmal reentrant supraventricular tachycardia","volume":"4","author":"Gmeiner","year":"1982","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.ccep.2010.07.003_bib94","doi-asserted-by":"crossref","first-page":"63D","DOI":"10.1016\/0002-9149(87)90711-9","article-title":"Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia","volume":"60","author":"Lindsay","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-8703(83)90487-8","article-title":"Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia","volume":"105","author":"Sakurai","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib96","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0002-8703(81)90227-1","article-title":"Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome","volume":"101","author":"Hamer","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib97","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-9149(84)90399-0","article-title":"Combined verapamil and propranolol for supraventricular tachycardia","volume":"53","author":"Yee","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib98","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.52.5.779","article-title":"Effect of digitalis in patients with paroxysmal atrioventricular nodal tachycardia","volume":"52","author":"Wellens","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib99","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/138161208784007716","article-title":"Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients","volume":"14","author":"Bouhouch","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ccep.2010.07.003_bib100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0002-9149(98)00232-X","article-title":"Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood","volume":"82","author":"Pfammatter","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib101","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2165\/00003495-199142060-00006","article-title":"Cardiac arrhythmias in childhood. Diagnostic considerations and treatment","volume":"42","author":"Strasburger","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.ccep.2010.07.003_bib102","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-97-2-175","article-title":"Digoxin, propranolol, and atrioventricular reentrant tachycardia in the Wolff-Parkinson-White syndrome","volume":"97","author":"Hung","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib103","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.amjcard.2003.06.002","article-title":"Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and\/or propranolol therapy","volume":"92","author":"Tortoriello","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib104","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/106002809703101016","article-title":"Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry","volume":"31","author":"Luedtke","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccep.2010.07.003_bib105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0002-9149(86)90614-4","article-title":"Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome","volume":"57","author":"Ward","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib106","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9149(86)90245-6","article-title":"Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate","volume":"58","author":"Kim","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/0003-4819-114-3-189","article-title":"Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia","volume":"114","author":"Cockrell","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib108","doi-asserted-by":"crossref","first-page":"23D","DOI":"10.1016\/0002-9149(88)90498-5","article-title":"Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia","volume":"62","author":"Zee-Cheng","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib109","doi-asserted-by":"crossref","first-page":"83A","DOI":"10.1016\/S0002-9149(97)89122-9","article-title":"Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia","volume":"77","author":"Hellestrand","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib110","doi-asserted-by":"crossref","first-page":"72A","DOI":"10.1016\/S0002-9149(97)89121-7","article-title":"Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group","volume":"77","author":"Hopson","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib111","doi-asserted-by":"crossref","first-page":"89A","DOI":"10.1016\/S0002-9149(97)89123-0","article-title":"A\u00a0randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group","volume":"77","author":"Dorian","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib112","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.78.4.863","article-title":"Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia","volume":"78","author":"Musto","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib113","first-page":"2550","article-title":"A\u00a0randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group","volume":"92","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib114","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.76.4.810","article-title":"Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome","volume":"76","author":"Mitchell","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib116","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.CIR.75.5.1050","article-title":"Sotalol in patients with Wolff-Parkinson-White syndrome","volume":"75","author":"Kunze","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/mhj.2001.115439","article-title":"Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo","volume":"142","author":"Tendera","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib118","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199709000-00015","article-title":"Clinical and\u00a0electrophysiologic effects of dofetilide in patients\u00a0with supraventricular tachyarrhythmias","volume":"30","author":"Kobayashi","year":"1997","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.ccep.2010.07.003_bib119","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(74)90200-8","article-title":"Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride","volume":"34","author":"Rosenbaum","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0002-9149(76)90148-X","article-title":"Effect of amiodarone in the Wolff-Parkinson-White syndrome","volume":"38","author":"Wellens","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib121","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0735-1097(84)80191-6","article-title":"Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes","volume":"3","author":"Feld","year":"1984","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib122","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.CIR.69.1.120","article-title":"A\u00a0comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient","volume":"69","author":"Wellens","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.07.003_bib123","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0002-8703(88)90524-8","article-title":"Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome","volume":"115","author":"Feld","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib124","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00003246-198610000-00011","article-title":"Verapamil infusions in the treatment of atrial tachyarrhythmias","volume":"14","author":"Barbarash","year":"1986","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib125","first-page":"1321","article-title":"Atrial tachycardia from enhanced automaticity in children: diagnosis and initial management","volume":"84","author":"Khongphatthanayothin","year":"2001","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"Suppl E","key":"10.1016\/j.ccep.2010.07.003_bib126","first-page":"E10","article-title":"\u2018True\u2019 atrial tachycardia","volume":"19","author":"Steinbeck","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib127","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/oxfordjournals.eurheartj.a060075","article-title":"Atrial automatic tachycardia in infancy and childhood","volume":"13","author":"von Bernuth","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib128","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0735-1097(10)80025-7","article-title":"Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up","volume":"15","author":"Haines","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2010.07.003_bib129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1536\/ihj.30.301","article-title":"The effective treatment of multifocal atrial tachycardia with amiodarone","volume":"30","author":"Kouvaras","year":"1989","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.ccep.2010.07.003_bib130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1378\/chest.91.1.68","article-title":"Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes","volume":"91","author":"Hazard","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.ccep.2010.07.003_bib131","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-107-5-623","article-title":"Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment","volume":"107","author":"Salerno","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib132","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00003246-198706000-00010","article-title":"Metoprolol in the treatment of multifocal atrial tachycardia","volume":"15","author":"Arsura","year":"1987","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccep.2010.07.003_bib133","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(88)80088-3","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia","volume":"85","author":"Arsura","year":"1988","journal-title":"Am J Med"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918210001048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918210001048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:37:39Z","timestamp":1740681459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918210001048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1877918210001048"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2010.07.003","relation":{},"ISSN":["1877-9182"],"issn-type":[{"type":"print","value":"1877-9182"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}